These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22311386)

  • 1. Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels.
    Qi TY; Chen YQ; Jiang J; Zhu YK; Yao XH; Wang XJ
    Int Urol Nephrol; 2012 Jun; 44(3):807-15. PubMed ID: 22311386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels.
    Tanaka N; Fujimoto K; Chihara Y; Torimoto M; Hirao Y; Konishi N; Saito I
    Prostate Cancer Prostatic Dis; 2007; 10(3):274-8. PubMed ID: 17339878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N; Fujimoto K; Yoshikawa M; Tanaka M; Hirao Y; Kondo H; Saito I
    Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
    Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    Int J Urol; 2005 Oct; 12(10):881-5. PubMed ID: 16323981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml
    Wang C; Wang YY; Wang SY; Ding JX; Ding M; Ruan Y; Wang XH; Jing YF; Han BM; Xia SJ; Jiang CY; Zhao FJ
    Asian J Androl; 2021; 23(4):415-420. PubMed ID: 33473011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL.
    Zheng XY; Xie LP; Wang YY; Ding W; Yang K; Shen HF; Qin J; Bai Y; Chen ZD
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1207-10. PubMed ID: 18446367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of magnetic resonance imaging-based prostate-specific antigen density of the prostate in the diagnosis of prostate cancer.
    Hoshii T; Nishiyama T; Toyabe S; Akazawa K; Komatsu S; Kaneko M; Hara N; Takahashi K
    Int J Urol; 2007 Apr; 14(4):305-10. PubMed ID: 17470159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4ng/ml.
    Ohi M; Ito K; Suzuki K; Yamamoto T; Yamanaka H
    Eur Urol; 2004 Jan; 45(1):92-6; discussion 96-7. PubMed ID: 14667523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml (-1) and 10.1-20.0 ng ml (-1) : a multicenter study.
    Lin YR; Wei XH; Uhlman M; Lin XT; Wu SF; Diao PF; Xie HQ; Xie KJ; Tang P
    Asian J Androl; 2015; 17(3):503-7. PubMed ID: 25475661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
    Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
    Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.
    Ng CF; Chiu PK; Lam NY; Lam HC; Lee KW; Hou SS
    Int Urol Nephrol; 2014 Apr; 46(4):711-7. PubMed ID: 24136184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An artificial neural network to predict the outcome of repeat prostate biopsies.
    Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
    Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.
    Teoh JY; Yuen SK; Tsu JH; Wong CK; Ho BS; Ng AT; Ma WK; Ho KL; Yiu MK
    Asian J Androl; 2017; 19(1):113-116. PubMed ID: 26620456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population.
    Wu YS; Wu XB; Zhang N; Jiang GL; Yu Y; Tong SJ; Jiang HW; Mao SH; Na R; Ding Q
    Asian J Androl; 2018; 20(4):324-329. PubMed ID: 29405172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].
    Martínez Jabaloyas JM; García Morata F; Villamón Fort R; Pastor Hernández F; Gil Salom M; García Sisamón F
    Actas Urol Esp; 2003 Jun; 27(6):442-9. PubMed ID: 12918151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.